Showing results (371-380 of 393) with videos related to
Sort By:
Pageof 40
Annals of the New York Academy of Sciences|January 1, 1987
Role of basement membranes in cell differentiationH K Kleinman, J Graf, Y Iwamoto, et al.Pharmacological Reviews|June 1, 1994
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)D Hoyer, D E Clarke, J R Fozard, et al.Journal of Medicinal Chemistry|September 1, 1995
Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine propertiesR C Glen, G R Martin, A P Hill, et al.Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995
Meso1, a basic-helix-loop-helix protein involved in mammalian presomitic mesoderm developmentM A Blanar, P H Crossley, K G Peters, et al.The Journal of Pediatrics|February 1, 1993
Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenationA Lotze, G R Knight, G R Martin, et al.Critical Care Medicine|April 1, 1997
Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalateV A Karle, B L Short, G R Martin, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1992
A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factorA Passaniti, R M Taylor, R Pili, et al.Journal of the American College of Cardiology|August 1, 1995
Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reportsD G Holley, G R Martin, J I Brenner, et al.Journal of the National Cancer Institute|June 5, 1991
Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with MatrigelR Fridman, M C Kibbey, L S Royce, et al.British Journal of Pharmacology|May 1, 1997
Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan)G R Martin, A D Robertson, S J MacLennan, et al.Pageof 40